Effects of Semaglutide on Muscle Structure and Function in the SLIM LIVER Study
Clinical Infectious Diseases · 24.02.2025 · 80 (2) · 389-396
DOI: 10.1093/cid/ciae384 ↗Kurz gefasst
Klinische Studie (Phase II) in der Zeitschrift Clinical Infectious Diseases, online erschienen am 24.07.2024. Verfasst von Grace L Ditzenberger und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA. Hauptthemen laut MEDLINE: Fatty Liver, Glucagon-Like Peptides, HIV Infections, Muscle, Skeletal. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NIH, NIAID NIH HHS.
Abstract (Originalsprache)
Background
Semaglutide is highly effective for decreasing weight. Concomitant loss of muscle mass often accompanies weight loss and may have consequences on muscle function.
Methods
This is a secondary analysis from the SLIM LIVER (Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections, ACTG A5371) study, a single-arm study of semaglutide in people with human immunodeficiency virus (HIV, PWH) with metabolic dysfunction–associated steatotic liver diseases (MASLD). Participants received subcutaneous semaglutide for 24 weeks (titrated to 1 mg/week by week 4). Psoas volume and fat fraction were assessed from liver magnetic resonance imaging, and physical function was assessed by 10-time chair rise test and 4 m gait speed. Mean change from baseline to week 24 was estimated with linear regression modeling.
Results
Fifty-one PWH were enrolled (muscle measures n = 46). The mean age was 50 years (standard deviation, 11), body mass index was 35.5 kg/m2 (5.6), 43% were women, 33% Black, and 39% Hispanic/Latino. Psoas muscle volume decreased by 9.3% (95% confidence interval [CI]: −13.4 to −5.2; P < .001) over 24 weeks, but psoas muscle fat did not significantly change (−0.42%; 95% CI: −1.00 to .17; P = .16). Chair rise and gait speed showed nonsignificant improvements of 1.27 seconds (95% CI: −2.7 to .10) and 0.05 m/sec (95% CI: −.01 to .10), respectively (both P > .07). The prevalence of slow gait speed (<1 m/sec) decreased from 63% to 46% (P = .029).
Conclusions
In PWH receiving semaglutide for MASLD, despite decreased psoas muscle volume, there was no significant change in physical function, suggesting function was maintained despite significant loss of muscle. Clinical Trials Registration NCT04216589.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
- Department of Internal Medicine, UTHealth, Houston, Texas, USA.
- Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA.
- School of Engineering Medicine, Texas A&M University, Houston, Texas, USA.
- National Institute of Allergy and Infectious Diseases (Contractor), Rockville, Maryland, USA.
- Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
ORCID-Profile: Grace L Ditzenberger, Jordan E Lake, Raja Muthupillai, Carlee Moser, Kristine M Erlandson
Förderung
- NIDDK NIH HHS
- NIH
- NIAID NIH HHS
- NIA NIH HHS
- NIAID
- McGovern School of Medicine at UTHealth
- National Institute on Aging
Zitieren
APA
Ditzenberger, G. L., Lake, J. E., Kitch, D. W., Kantor, A., Muthupillai, R., Moser, C., Belaunzaran-Zamudio, P. F., Brown, T. T., Corey, K., Landay, A. L., Avihingsanon, A., Sattler, F. R., & Erlandson, K. M. (2025). Effects of Semaglutide on Muscle Structure and Function in the SLIM LIVER Study. Clinical Infectious Diseases, 80(2), 389-396. https://doi.org/10.1093/cid/ciae384
Vancouver
Ditzenberger GL, Lake JE, Kitch DW, Kantor A, Muthupillai R, Moser C, et al. Effects of Semaglutide on Muscle Structure and Function in the SLIM LIVER Study. Clinical Infectious Diseases. 2025;80(2):389-396. doi:10.1093/cid/ciae384
BibTeX
@article{Ditzenberger2025,
author = {Ditzenberger, Grace L and Lake, Jordan E and Kitch, Douglas W and Kantor, Amy and Muthupillai, Raja and Moser, Carlee and Belaunzaran-Zamudio, Pablo F and Brown, Todd T and Corey, Kathleen and Landay, Alan L and Avihingsanon, Anchalee and Sattler, Fred R and Erlandson, Kristine M},
title = {Effects of Semaglutide on Muscle Structure and Function in the SLIM LIVER Study},
journal = {Clinical Infectious Diseases},
year = {2025},
volume = {80},
number = {2},
pages = {389--396},
doi = {10.1093/cid/ciae384}
}
EUVIMED